Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes

Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Jesus G. Berdeja, Yasmin Abaza, Elias Jabbour, James Essell, Roger M. Lyons, Farhad Ravandi, Michael Maris, Brian Heller, Amy E. DeZern, Sunil Babu, David Wright, Bertrand Anz, Ralph Boccia, Rami S. Komrokji, Philip Kuriakose, James Reeves, Mikkael A. Sekeres, Hagop M. KantarjianRichard Ghalie, Gail J. Roboz

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences